Stock FLAC FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Frazier Lifesciences Acquisition Corporation

Equities

FLAC

KYG3710A1058

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib
AQ
NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease Patients
AQ
Frazier Lifesciences Acquisition Corporation shareholders approve business combination with NewAmsterdam Pharma Holding B.V
AQ
FRAZIER LIFESCIENCES ACQUISITION CORP : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.
BU
Frazier Lifesciences Acquisition : shareholders approve business combination with NewAmsterdam Pharma Holding B.V.
PU
FRAZIER LIFESCIENCES ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
FRAZIER LIFESCIENCES ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Frazier Lifesciences Acquisition : NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger - Form 8-K/A
PU
FRAZIER LIFESCIENCES ACQUISITION CORP Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A)
AQ
Frazier Lifesciences Acquisition : NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger - Form 8-K
PU
FRAZIER LIFESCIENCES ACQUISITION CORP : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic Diseases
BU
FRAZIER LIFESCIENCES ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
FRAZIER LIFESCIENCES ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
FRAZIER LIFESCIENCES ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
AQ
FRAZIER LIFESCIENCES ACQUISITION CORP - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.
AQ
FRAZIER LIFESCIENCES ACQUISITION CORP : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
FRAZIER LIFESCIENCES ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
FRAZIER LIFESCIENCES ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FLAC Stock
  4. News Frazier Lifesciences Acquisition Corporation
  5. Press Releases